CTOs on the Move

LEXEO Therapeutics

www.lexeotx.com

 
LEXEO Therapeutics is a New York City-based, fully integrated biotechnology company currently headquartered at the Alexandria Center® for Life Science that aims to apply the transformational science of gene therapy to address some of the world’s most devastating genetic and acquired diseases.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million
  • www.lexeotx.com
  • 430 East 29th Street 14th Floor
    New York, AB USA 10016
  • Phone: 212.547.9879

Executives

Name Title Contact Details

Funding

LEXEO Therapeutics raised $85M on 01/07/2021

Similar Companies

Synsorb Biotech

Synsorb Biotech Inc. is a Calgary, AB-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cleave Biosciences

Cleave Biosciences is a biopharmaceutical company pioneering the development of novel protein homeostasis inhibitors for the treatment of cancer.

Mind Medicine

MindMed is a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders. Our mission is to be the global leader in the development and delivery of treatments that unlock new opportunities to improve patient outcomes. We are developing a pipeline of innovative product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways that play key roles in brain health disorders. MindMed trades on NASDAQ under the symbol MNMD and on the Canadian NEO Exchange under the symbol MMED.

Progenics

Progenics is a North York, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

NextBio

NextBio is a Santa Clara, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.